National Journal: February 20, 2014
Opinion: African-Americans, at 12 percent of the population, comprise only 5 percent of clinical-trial participants; the numbers for Hispanics are 16 percent and 1 percent. It’s time for that inequity to change, PhRMA’s CEO says.
When a patient picks up her prescription for rheumatoid arthritis, she knows it will enable her to hold her grandson with less pain. The heart-disease survivor takes his statin to avoid bypass surgery that could significantly impact his quality of life. Medical innovations have the power to change lives, as these examples demonstrate. Read More